AJMC November 15, 2024
Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.
This article was originally published on Pharmacy Times®.
A new study findings published in The Lancet assessed the effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated hospitalizations and emergency department encounters among individuals at least 60 years of age. The study was conducted to confirm RSV vaccine effectiveness found in clinical trials against lower respiratory tract disease using real world data.1
According to the CDC, the US experiences up to 160,000 hospitalizations and around 10,000 deaths among older adults due to RSV infection each year. Symptoms typically present like a mild cold but could become more severe...
Today's Sponsors
Today's Sponsor